T1D Early Detection campaign

Breakthrough T1D is leading a campaign to secure a positive recommendation from the USPSTF for type 1 diabetes screening.

The campaign

Make early detection of T1D the standard of care

The USPSTF (United States Preventative Services Task Force) provides recommendations for preventative care, which serve as the gold standard for clinicians and providers. This campaign will include key clinicians, research experts, clinical organizations, and advocates.

Drawing from the decades of global research available on the benefits of detecting type 1 diabetes (T1D) early, together we will compile an evidence base to submit to the USPSTF for review.

FAQ

Why USPSTF?

  • The USPSTF is an independent body of experts appointed by the U.S. Secretary of Health and Human Services (HHS) to evaluate and make evidence-based recommendations on how to improve the health of Americans. 
  • The USPSTF’s recommendations cover a wide range of preventive services, including screenings, counseling, and medications.
  • Services recommended by the USPSTF are required to be covered at no out-of-pocket cost by health plans and government programs. 
  • Breakthrough T1D and other leading institutions have sponsored T1D screening programs and research for decades.
  • This vast wealth of data and information can be used to demonstrate the value of early detection by meeting the rigorous evidence review requirements of the USPSTF and better integrate T1D screening into the U.S. healthcare system. 

Why early detection of T1D?

  • Thanks to decades of research, we can now detect type 1 diabetes in its earliest stages with a simple blood test.
  • This blood test can identify people who have proteins in their blood called autoantibodies.
  • These autoantibodies signal that the body’s immune system is attacking the insulin producing cells in the pancreas.
  • If a person has two or more persistent autoantibodies, they are very likely to develop type 1 diabetes. 
  • With early detection, it’s possible to reduce the risk for diabetic ketoacidosis (DKA) at diagnosis, identify people who may benefit from clinical trials, give families time to prepare, and provide the option to intervene early with FDA-approved therapies to delay the need for insulin.
  • If you have positive test results, you will also be able to develop a plan for further monitoring with your doctor to avoid an emergency diagnosis.

Where can I learn more about T1D early detection?

Join the campaign

Contact us to support our USPSTF T1D early detection campaign and join our kick-off meeting on Tuesday, January 14, 2025, to learn more. 

Contact Us Now